Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05435794 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients

Study acronym: REMAP
StatusRecruiting
PhaseNot specified
SponsorResMed
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study completion date: Oct 15, 2022 to Oct 15, 2026
    • Eligibility criteria expanded, about 25 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ResMed
18 trials monitored
See 2 trials at risk
The REMAP study aims to follow a cohort of 400 patients in around ten sleep centers in France and to collect clinical routine data. The objectives of this study are to investigate the effects of one-year management of OSA by CPAP or MAD on sleep architecture defined by objective macro and micro sleep architecture parameters using a sleep test device. sleep connected at home, to assess the quality of sleep and the quality of life reported by patients. The study will also allow us to define predictive factors for improving sleep quality during OSA treatment.
Trial Details
NCT Number NCT05435794
Lead Sponsor ResMed
Conditions
(from sponsor)		 OSA
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov